发明名称 VECTORS FOR EXPRESSION OF HML-2 POLYPEPTIDES
摘要 <p>A nucleic acid vector comprising: (i) a promoter; (ii) a sequence encoding an HML-2 polypeptide operably linked to said promoter; and (iii) a selectable marker. Preferred vectors comprise: (I) an eukaryotic promoter; (ii) a sequence encoding an HML-2 polypeptide downstream of and operably linked to said promoter, (iii) a prokaryotic selectable marker; (iv) a prokaryotic origin of replication; and (v) an eukaryotic transcription terminator downstream of and operably linked to said sequence encoding an HML-2 polypeptide. Vectors of the invention are particularly useful for expression of HML-2 polypeptides either in vitro (e.g. for later purification). Or in vivo (e.g. for nucleic acid immunization). They are well suited to nucleic acid immunization against prostrate tumors. A preferred HML-2 is PCAV, which is located in chromosome 22 at 20.428 megabases (22q11.2). A virus-like particle (VLP) comprising HML-2 gag polypeptides and its use in immunization and treatment or diagnosis of prostate tumor.</p>
申请公布号 EP1532161(B1) 申请公布日期 2012.02.15
申请号 EP20030741966 申请日期 2003.06.13
申请人 NOVARTIS VACCINES AND DIAGNOSTICS, INC. 发明人 HARDY, STEPHEN, F.;DONNELLY, JOHN, J., III;ZUR MEGEDE, JAN, T.
分类号 C07H21/04;C12N15/09;A61K31/7088;A61K35/76;A61K39/00;A61K39/21;A61K48/00;A61P3/10;A61P25/00;A61P35/00;C12N7/00;C12N7/01;C12N15/48;C12N15/63;C12N15/74;G01N33/569 主分类号 C07H21/04
代理机构 代理人
主权项
地址